Introduction
Hereditary long QT syndromes (LQTS) are cardiac repolarization abnormalities characterized by a prolonged QT interval on the surface ECG. LQTS are associated with syncope and a high risk of sudden cardiac death due to ventricular tachyarrhythmias [1] . More than 700 mutations in twelve different genes have been described to date [2] . LQTS1, the most frequent form of LQTS, is associated with KCNQ1 (KvLQT1) gene mutations [3] . Co-expression of the poreforming α-subunit KCNQ1 and its regulatory β-subunit KCNE1 (minK) elicits slowly activating potassium currents, resembling the slow component of the cardiac delayed rectifier potassium current I Ks [4, 5] . I Ks contributes to cardiac repolarization and is a target for class III antiarrhythmic drugs such as dronedarone [6] . Loss-of-function mutations in KCNQ1 lead to prolonged cardiac repolarization and cause congenital long QT syndrome 1 [7] [8] [9] [10] [11] [12] . In contrast, KCNQ1 gain-of-function mutations may induce short QT syndrome [13] or hereditary atrial fibrillation [14] .
Previous work on genotype-phenotype correlations has indicated that the individual LQTS genotype influences the clinical course [15, 16] . Approximately one third of KCNQ1 mutations identified in LQTS patients are located in the pore region or in adjacent transmembrane regions, S5 and S6 [17] . Carriers of these mutations exhibit a higher risk for cardiac events and tend to be affected at younger ages compared to patients with mutations in the C-terminal region [18, 19] . Furthermore, Moss et al. [20] revealed that location of KCNQ1 mutations in the pore and transmembrane regions and dominant-negative current suppression in vitro may serve as predictors of severe clinical courses independent of traditional clinical risk factors, suggesting potential significance for therapy planning in LQTS patients.
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In the present study, we analyze biophysical properties of mutant KCNQ1 S277L potassium channels identified in a German LQTS family. This mutation is located in the S5 transmembrane region of the KCNQ1 channel and causes loss of channel function. However, closely related family members display phenotypic variability ranging from asymptomatic QTc prolongation to recurrent ventricular tachycardia despite harbouring the same mutation associated with a severe cellular phenotype. We conclude that modifying factors contribute to the individual clinical phenotype to a larger extent than previously appreciated.
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Materials and methods
Pedigree and mutation analysis
Clinical evaluation and blood samples are based on a LQTS family of German origin ( Figure 1A ). The index patient (II.4, female) was brought to our attention after recurrent syncope and aborted sudden death had occurred during emotional stress.
The investigation conforms to the principles outlined in the Declaration of Helsinki.
Informed consent was obtained for genetic analyses. DNA sequence analyses were performed by the Center for Human Genetics and Laboratory Medicine (Martinsried, Germany).
Molecular biology
Complementary DNA encoding human KCNQ1 and human KCNE1 was kindly provided by Dr. Steve Goldstein (Chicago, USA). To introduce the S277L mutation into KCNQ1, site-directed PCR-mutagenesis was performed using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, USA) as described [21] , and resulting cDNA was analysed by DNA sequence analysis.
Heterologous gene expression in Xenopus laevis oocytes
Procedures for in vitro transcription and oocyte injection have been published previously [9] . Briefly, WT KCNQ1, KCNQ1 S277L, and KCNE1 cRNAs were prepared with the mMESSAGE mMACHINE kit (Ambion, Austin, USA) using T7 RNA 
Electrophysiology and data analysis
Two-microelectrode voltage-clamp recordings from Xenopus laevis oocytes were carried out as published previously [9] . Voltage clamp measurements of
Xenopus oocytes were performed in a solution containing (in mM): 5 KCl, 100 NaCl, To assess half-maximal activation voltages, activation curves were fit with a Boltzmann distribution:
where V is the test pulse potential, V 1/2 is the half-maximal activation potential, and k is the slope of the activation curve.
Statistics
Data are expressed as mean ± standard error of the mean (SEM). Unpaired Student's t tests (two-tailed tests) were used to compare the statistical significance of the results: p < 0.05 was considered statistically significant. Multiple comparisons were performed using one-way ANOVA. If the hypothesis of equal means could be rejected at the 0.05-level, pairwise comparisons of groups were made and the probability values were adjusted for multiple comparisons using the Bonferroni correction.
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Results
Clinical analysis and genetics
The (Fig. 1B) . In order to identify the underlying mutation, genomic DNA from the index patient and from two additional family members was sampled. DNA sequence analyses revealed C to T transversions at nucleotide position 830 of all patients available for genetic assessment. As a result, a conserved serine residue was replaced by leucine at position 277 located in the S5 transmembrane segment of the KCNQ1 ion channel polypeptide (Fig. 1E ).
Electrophysiological analysis of mutant KCNQ1 S277L channels
Homomultimeric channels formed by wild type (WT) or mutant KCNQ1 S277L subunits were functionally characterized in Xenopus oocytes injected with the respective cRNA (23 ng each). Currents were activated during depolarizing steps to potentials ranging from -60 mV to +120 mV (2 s), and tail currents were recorded at -40 mV (2 s). The holding potential was -80 mV, and pulses were applied at a frequency of 0.2 Hz. This voltage protocol was used in all electrophysiological measurements in this work. Tail currents represent KCNQ1 channel activity, while outward currents during the first step of the voltage protocol may in part reflect low
endogenous Xenopus currents (compare Fig. 2A and Fig. 2D ). Thus, tail current amplitudes were analysed. Mean WT KCNQ1 current amplitudes yielded 0.61 ± 0.03 µA (n = 21; Fig. 2A and 2E ), while virtually no tail current was detected in oocytes injected with mutant KCNQ1 S277L cRNA (0.01 ± 0.01 µA; n = 21; Fig. 2B and 2E ).
KCNQ1-associated long QT syndrome is inherited in an autosomal-dominant manner, and affected individuals carry one WT and one mutant KCNQ1 allele.
Dominant inheritance might be explained either by haploinsufficiency or by dominantnegative effects of mutant subunits on their WT counterparts. To examine whether KCNQ1 S277L subunits cause dominant-negative current suppression, WT KCNQ1 cRNA (11.5 ng, i.e. 50% of the amount injected in Fig. 2A ) and mutant KCNQ1 S277L cRNA (11.5 ng, i.e. 50% of the amount injected in Fig. 2B ) were co-injected into oocytes, and the resulting currents (Fig. 2C) were compared with WT KCNQ1 currents ( Fig. 2A ). Mean KCNQ1 current amplitudes were reduced by 88.5 % to 0.07 ± 0.01 µA (n = 21; Fig. 2C and 2E) compared to WT KCNQ1 currents, indicating that dominant-negative suppression of WT KCNQ1 causes current reduction in the absence of KCNE1 β-subunits.
KCNQ1 S277L causes dominant-negative I Ks suppression
In human cardiomyocytes, the pore forming α-subunit KCNQ1 and the ß-subunit KCNE1 form channels with characteristics largely similar to I Ks [4, 5] . To determine whether the mutants exert a dominant-negative effect in the presence of KCNE1 subunits as well, we co-expressed WT and mutant KCNQ1 S277L subunits in equimolar amounts. The resulting outward potassium current after injection of WT KCNQ1 (11.5 ng) and KCNE1 (11.5 ng) cRNA displayed properties nearly identical to those of native cardiac I Ks , with mean tail current amplitudes of 1.10 ± 0.12 µA (n = = 73.5 ± 1.3 mV; n = 15). In all other experiments in this study a reasonable analysis of activation curves was prevented by low I Ks tail current amplitudes.
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Discussion
A KCNQ1 point mutation was identified in German LQTS1 family, resulting in replacement of a highly conserved serine residue located in the S5 transmembrane region of the channel by leucine (KCNQ1 S277L; Fig. 1E ). Electrophysiological characterisation revealed that KCNQ1 S277L subunits did not produce functional potassium channels and suppressed WT KCNQ1 in dominant-negative manner in the presence and in the absence of KCNE1. The half-maximal activation curve of I Ks produced by co-expression of WT KCNQ1 and KCNQ1 S277L with KCNE1 was shifted towards more negative potentials, indicating direct interaction of wild type and mutant subunits. This activation shift in isolation is expected to result in increased current amplitudes at a given membrane potential. However, current increase was not observed owing to strong current suppression by mutant KCNQ1.
The severe electrophysiological phenotype may be readily explained by the location of the affected amino acid. KCNQ1 mutations in the S5-pore-S6 region of the channel generally appear to be associated with more severe clinical presentation [22] . The serine residue at position 277, which is located next to the extracellular surface of the S5 segment in close proximity to the pore helix, is highly conserved in the family of KCNQ channels and among other potassium channels (Fig. 1E ).
KCNQ1 mutations replacing serine 277 are predicted to cause changes in the pore architecture that significantly affect ion conductance and result in channel dysfunction. Our experimental data revealed that replacement of S277 by leucine prevented KCNQ1 channel function, confirming the hypothesis that this residue is essential for structural integrity and function of the KCNQ1 pore complex.
Furthermore, Gouas et al. reported KCNQ1 trafficking inhibition caused by mutation
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Patients with KCNQ1 mutations located in transmembrane regions of the channel exhibit an increased risk of cardiac arrhythmias compared to patients with mutations in the C-terminus [18] [19] [20] . Furthermore, dominant-negative in vitro effects of KCNQ1 mutations have recently been identified as independent risk factor for more severe clinical courses of LQTS [20] . Here, the index patient carrying the KCNQ1 S277L mutation was sensitive to stress-induced ventricular arrhythmia. She exhibited a relatively long QTc interval and a severe clinical phenotype (recurrent syncope and tachycardia, aborted sudden death). This corresponds well to the cellular phenotype, i.e. inactive ion channels and dominant-negative I Ks suppression.
In contrast, we identified three asymptomatic family members with LQTS (SchwartzScore ≥ 4 [1, 24] ), indicating that genotype-phenotype correlations should be handled with care since I Ks suppression evaluated in heterologous expression systems may not always correlate well with severity of the clinical phenotype [25] . This notion is supported by additional studies that did not reveal a consistent correlation between KCNQ1 genotype and clinical phenotype [10, 15, 17] . Limitations of this study arise from the fact that genetic sequencing was not performed in additional ion channel genes to screen for second mutations after the mutation in KCNQ1 was identified in our patients. Thus, some of the S277L mutation carriers may have carried a second mutation, potentially modifying the clinical phenotype.
Mutations of KCNQ1 S277 have been reported previously (∆S277, S277L, S277W [19, 20, 26, 27] ). However, detailed clinical and/or biophysical data are limited.
Liu et al. [26, 27] reported four S277L mutation carriers, of which two died suddenly A C C E P T E D M A N U S C R I P T
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(QTc = 540 and 680 ms, respectively) and two remained asymptomatic (QTc = 470 ms in both subjects). In contrast to the index patient reported in our study, the affected patients died following exercise and excitement which more frequently triggers arrhythmias in LQTS1 than emotional stress. In summary, these clinical observations confirm high phenotypic variability associated with KCNQ1 S277
mutations.
In conclusion, the KCNQ1 S277L mutation causes long QT syndrome 1. The clinical severity of KCNQ1-associated long QT syndrome 1, however, does not solely depend on the disease-causing mutation itself. Rather, it appears to be determined by additional factors, such as compound mutations, low penetrance, and the individual repolarization reserve, comprising genetic, epigenetic, hormonal, and environmental factors [14, 29, 30] . In particular, the KCNE1 D85N polymorphism was recently revealed to reduce I Ks amplitudes [31] . Thus, phenotypic variability may depend on the presence or absence of KCNE1 polymorphisms in KCNQ1 S277L gene carriers. 
Figure Legends
